Wegovy Benefits: Weight Loss, Heart, and Liver Data

What Are the Benefits of Wegovy?

Wegovy (semaglutide) is FDA-approved for three separate uses: chronic weight management in adults with obesity or overweight plus a weight-related condition; reducing the risk of heart attack, stroke, and cardiovascular death in adults with established heart disease and overweight or obesity; and, most recently, treating metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-advanced liver fibrosis. Each approval rests on its own dedicated clinical trial program, not one shared data set.

Who Qualifies for Each Indication

The BMI and diagnosis criteria differ by indication, and mixing them up is a common source of confusion. For weight management, a BMI of 30 or higher qualifies on its own, since that's the clinical definition of obesity; a BMI between 27 and 29.9 qualifies only with at least one weight-related condition, such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea. Adolescents 12 and older qualify at a BMI at or above the 95th percentile for their age and sex.

The cardiovascular indication applies to adults 45 and older with established cardiovascular disease, a prior heart attack, prior stroke, or peripheral arterial disease, and a BMI of 27 or higher; this pathway does not require the higher BMI-30 obesity threshold, because the qualifying factor is the cardiovascular history, not the weight number alone. The MASH indication requires a confirmed diagnosis of moderate-to-advanced liver fibrosis without cirrhosis, typically established through imaging or biopsy rather than a BMI cutoff at all.

How Does Wegovy Work?

Wegovy's active ingredient, semaglutide, mimics a naturally occurring gut hormone called GLP-1 (glucagon-like peptide-1), which your intestines release after eating. Semaglutide binds the same GLP-1 receptors the natural hormone does, but stays active in the body for about a week per dose rather than the few minutes the natural hormone lasts, which is why Wegovy is injected weekly rather than continuously. That extended activity slows how quickly food empties from the stomach, signals fullness to the brain earlier in a meal, and improves how the body responds to insulin, three effects that together explain the weight-loss, cardiovascular, and metabolic benefits measured across Wegovy's three approvals. The MASH benefit, specifically, likely comes from a combination of the direct weight loss and semaglutide's separate anti-inflammatory effects on liver tissue, though the exact mechanism inside the liver is still an active area of research.

How Much Weight Can You Lose on Wegovy?

The STEP 1 trial, the pivotal study behind Wegovy's original weight-management approval, followed adults with obesity or overweight for 68 weeks. Participants taking semaglutide lost an average of 14.9% of their starting body weight, against 2.4% in the placebo group. Looking at how many people crossed specific thresholds tells a fuller story: 86.4% of the semaglutide group lost at least 5% of their body weight, 69.1% lost at least 10%, and 50.5%, roughly half, lost at least 15%. Those figures come from a population average measured under trial conditions with regular follow-up, not a guarantee for any individual reader.

Does Wegovy Lower the Risk of Heart Attack and Stroke?

Yes, this is Wegovy's second FDA-approved benefit, based on the SELECT trial, which enrolled more than 17,000 adults with established cardiovascular disease and overweight or obesity, without diabetes. Participants taking semaglutide had a 20% lower rate of major adverse cardiovascular events, the combined measure of cardiovascular death, non-fatal heart attack, and non-fatal stroke, compared with placebo. A notable detail from the same trial: the cardiovascular benefit held up regardless of how much weight a given participant actually lost, meaning the heart-protective effect isn't simply a side effect of the pounds coming off.

Can Wegovy Treat MASH (Fatty Liver Disease)?

Yes, as of August 15, 2025, making Wegovy the first GLP-1 receptor agonist FDA-approved for metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease, in adults with moderate-to-advanced liver fibrosis but not cirrhosis. The approval rests on Part 1 of the ESSENCE trial, which found a statistically significant improvement in liver fibrosis with no worsening of steatohepatitis, along with resolution of steatohepatitis with no worsening of fibrosis, compared with placebo. Part 2 of the ESSENCE trial, expected to read out in 2029, will add longer-term outcome data on top of these initial fibrosis and steatohepatitis findings.

Does Wegovy Lower Blood Pressure?

Weight loss on Wegovy commonly comes with a modest drop in blood pressure as a secondary effect of the weight change itself, rather than a separate, dedicated FDA-approved indication the way the cardiovascular-risk-reduction approval is. The SELECT trial's cardiovascular benefit is the more clinically significant heart-related finding, since it measures actual cardiovascular events rather than a blood pressure number alone. Anyone tracking their own blood pressure change on Wegovy should discuss it with their prescriber rather than treat it as a separately guaranteed benefit.

Ozempic vs Wegovy: Do They Share These Benefits?

Ozempic and Wegovy are both semaglutide, but the FDA approved them separately, Ozempic for type 2 diabetes at a lower maximum dose, Wegovy for the three uses above at a higher, weight-management dose. That distinction is exactly why an insurer's coverage answer for one doesn't automatically apply to the other; see our Humana + Wegovy coverage guide for how that plays out for a specific insurer. Our Ozempic vs Wegovy comparison covers the dose and indication differences in full.

What to Look For in a Body-Composition Scale

A bioimpedance scale trends body fat and muscle rather than just weight — useful when the number stalls but your composition is improving. The absolute body-fat % isn't lab-accurate, so use it for TRENDS at a consistent time of day. Choose one that syncs to an app so you can watch the trend line.

GE Smart Scale for Body Weight: 8-Electrode Digital Bathroom Scale for Weight Fat BMI Muscle Mass Full Body Composition Analyzer 50 Measurements Bluetooth Highly Accurate Weighing Machine 400lb Black

GE

View on Amazon →

Etekcity Smart Scale for Body Weight, FSA&HSA Eligible, Bathroom Digital Weighing Scale with BMI, Body Fat, Muscle Mass, Accurate Bluetooth Home User Health Equipment Sync Apps, LED, Tempered glass

Etekcity

View on Amazon →